|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.69 BRL | +4.70% |
|
-4.12% | -21.46% |
| 07-24 | US FDA approves Outlook Therapeutics' eye disease drug | RE |
| 07-24 | Sanofi to Drop Eczema Drug Amid Review of Pipeline Under New CEO | DJ |
Chart: Technical Analysis
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- REGN Stock
- REGN34 Stock
- Charts Regeneron Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
